P142 A retrospective analysis of the safety of tacrolimus use and its optimal cut-off concentration during pregnancy in women with systemic lupus erythematosus: study from two Japanese tertiary referral centers

• Masato Okada,
• Takehiro Nakai,
• Ayako Kitada,
• Naoto Yokogawa,
• Nanase Honda,
• Sho Fukui,
• Eri Soga

Affiliations

Masato Okada

IRC, SLIH, Japan

Takehiro Nakai

1Immuno-Rheumatology Center, St. Luke’s International Hospital, Japan

Ayako Kitada

Immuno-Rheumatology Center, Saint-Luke’s International Hospital, Tokyo, Japan

Naoto Yokogawa

2Dept. of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan

Nanase Honda

Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Fuchu, Japan

Sho Fukui

1Immuno-Rheumatology Center, St. Luke’s International Hospital, Japan

Eri Soga

3Dept. of Obstetrics and Gynecology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan